Close Menu

Myriad Genetics and the American Civil Liberties Union are taking the next step in their court battle over the legitimacy of Myriad's BRCA patents. As our sister publication GenomeWeb Daily News reports, a US Federal Circuit Court of Appeals recently upheld Myriad's right to patent the genes, and then declined to rehear the case. The ACLU is now going to the Supreme Court in its bid to get the patents overturned.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.